[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Clinical and Economic Outcomes Associated with Aspiration Pneumonia in Hospitalized Patients with Parkinson’s Disease: A National Inpatient Sample Analysis",
    "section": "",
    "text": "Reference Papers:\n\nLuca et al. 2021\n\nStudy Objective: Examine the impact of aspiration pneumonia on in-hospital outcomes among inpatient admissions with Parkinson’s disease.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a diagnosis of Parkinson’s disease.\nAspirtaion Pneumonia + Parkinson’s Disease Categories:\n\nParkinson’s Disease with Aspirtaion Pneumonia\nParkinson’s Disease without Aspirtaion Pneumonia\n\nOutcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\nSepsis\nAcute respiratory failure\nMechanical Ventilation\nDischarge Disposition (Discharged to home, short term facility, or long-term facility)\nPalliative care utilization\n\nCovariates for Adjustment: All models adjusted for the following\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, residence (urbanicity), hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, cancer, hyperlipidemia, coronary artery disease, peripheral vascular disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, dementia, liver disease, fluid/electrolyte imbalance.\nComorbidities: Elixhauser comorbidity index.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Clinical and Economic Outcomes Associated with Aspiration Pneumonia in Hospitalized Patients with Parkinson’s Disease: A National Inpatient Sample Analysis",
    "section": "",
    "text": "Reference Papers:\n\nLuca et al. 2021\n\nStudy Objective: Examine the impact of aspiration pneumonia on in-hospital outcomes among inpatient admissions with Parkinson’s disease.\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a diagnosis of Parkinson’s disease.\nAspirtaion Pneumonia + Parkinson’s Disease Categories:\n\nParkinson’s Disease with Aspirtaion Pneumonia\nParkinson’s Disease without Aspirtaion Pneumonia\n\nOutcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\nSepsis\nAcute respiratory failure\nMechanical Ventilation\nDischarge Disposition (Discharged to home, short term facility, or long-term facility)\nPalliative care utilization\n\nCovariates for Adjustment: All models adjusted for the following\n\nDemographics: Age, sex, race, residential income, insurance, hospital region, hospital bedsize, residence (urbanicity), hospital location, and teaching status.\nMedical History: Hypertension, diabetes mellitus, cancer, hyperlipidemia, coronary artery disease, peripheral vascular disease, heart failure, chronic kidney disease, chronic obstructive pulmonary disease, dementia, liver disease, fluid/electrolyte imbalance.\nComorbidities: Elixhauser comorbidity index.\n\nStatistical Methods:\n\nUnivariable Analysis:\n\nCategorical variables: Compared using Pearson’s chi-square test with Rao & Scott adjustment\nContinuous variables: Analyzed using the design-based Kruskal–Wallis test, a non-parametric alternative suitable for survey-weighted data\n\nMultivariable Analysis:\n\nBinary outcomes (e.g., mortality): Survey-weighted logistic regression using the quasibinomial family\nContinuous outcomes (e.g., LOS, hospital charges): Survey-weighted linear regression using the gaussian family\nResults reported as adjusted odds ratios (aORs) or beta coefficients with 95% confidence intervals\n\n\nSoftware: All statistical analyses were performed using the R Statistical Language (Version 4.5.0; R Foundation for Statistical Computing, Vienna, Austria), incorporating survey-weighted procedures via the survey package to account for the complex sampling design of NIS."
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Clinical and Economic Outcomes Associated with Aspiration Pneumonia in Hospitalized Patients with Parkinson’s Disease: A National Inpatient Sample Analysis",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 1,040,0551\nParkinson’s disease without aspiration pneumonia\nN = 956,2001\nParkinson’s disease with aspiration pneumonia\nN = 83,8551\np-value2\n\n\n\n\nAge, y\n76 (10)\n76 (10)\n79 (9)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n424,615 (41%)\n400,175 (42%)\n24,440 (29%)\n\n\n\n\n    Male\n615,370 (59%)\n555,955 (58%)\n59,415 (71%)\n\n\n\n\nRace\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n814,410 (80%)\n751,640 (80%)\n62,770 (76%)\n\n\n\n\n    Asian or Pacific Islander\n26,440 (2.6%)\n22,385 (2.4%)\n4,055 (4.9%)\n\n\n\n\n    Black\n71,090 (7.0%)\n65,015 (7.0%)\n6,075 (7.4%)\n\n\n\n\n    Hispanic\n75,990 (7.5%)\n69,275 (7.4%)\n6,715 (8.2%)\n\n\n\n\n    Native American\n3,710 (0.4%)\n3,400 (0.4%)\n310 (0.4%)\n\n\n\n\n    Other\n25,335 (2.5%)\n23,025 (2.5%)\n2,310 (2.8%)\n\n\n\n\nElixhauser comorbidity index\n5.22 (2.21)\n5.19 (2.22)\n5.45 (2.14)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n256,635 (25%)\n238,155 (25%)\n18,480 (22%)\n\n\n\n\n    $52,000 - $65,999\n267,420 (26%)\n247,425 (26%)\n19,995 (24%)\n\n\n\n\n    $66,000 - $87,999\n255,535 (25%)\n234,700 (25%)\n20,835 (25%)\n\n\n\n\n    $88,000 or more\n245,930 (24%)\n222,555 (24%)\n23,375 (28%)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n&lt;0.001\n\n\n    Private\n84,765 (8.2%)\n79,035 (8.3%)\n5,730 (6.8%)\n\n\n\n\n    Medicaid\n33,200 (3.2%)\n30,930 (3.2%)\n2,270 (2.7%)\n\n\n\n\n    Medicare\n900,415 (87%)\n826,560 (87%)\n73,855 (88%)\n\n\n\n\n    Other\n20,625 (2.0%)\n18,725 (2.0%)\n1,900 (2.3%)\n\n\n\n\nHospital region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n242,055 (23%)\n224,765 (24%)\n17,290 (21%)\n\n\n\n\n    Northeast\n210,390 (20%)\n191,395 (20%)\n18,995 (23%)\n\n\n\n\n    South\n392,520 (38%)\n363,605 (38%)\n28,915 (34%)\n\n\n\n\n    West\n195,090 (19%)\n176,435 (18%)\n18,655 (22%)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n&lt;0.001\n\n\n    Large\n483,065 (46%)\n445,760 (47%)\n37,305 (44%)\n\n\n\n\n    Medium\n306,835 (30%)\n281,375 (29%)\n25,460 (30%)\n\n\n\n\n    Small\n250,155 (24%)\n229,065 (24%)\n21,090 (25%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n&lt;0.001\n\n\n    Rural\n109,195 (10%)\n101,360 (11%)\n7,835 (9.3%)\n\n\n\n\n    Urban, non-teaching\n219,625 (21%)\n201,090 (21%)\n18,535 (22%)\n\n\n\n\n    Urban, teaching\n711,235 (68%)\n653,750 (68%)\n57,485 (69%)\n\n\n\n\nResidence\n\n\n\n\n\n\n&lt;0.001\n\n\n    Central metro ≥1 million\n287,990 (28%)\n261,220 (27%)\n26,770 (32%)\n\n\n\n\n    Fringe metro ≥1 million\n268,570 (26%)\n245,815 (26%)\n22,755 (27%)\n\n\n\n\n    Metro 250,000-999,999\n207,990 (20%)\n192,365 (20%)\n15,625 (19%)\n\n\n\n\n    Metro 50,000-249,999\n99,850 (9.6%)\n93,085 (9.8%)\n6,765 (8.1%)\n\n\n\n\n    Micropolitan\n98,615 (9.5%)\n91,515 (9.6%)\n7,100 (8.5%)\n\n\n\n\n    Other\n74,655 (7.2%)\n69,910 (7.3%)\n4,745 (5.7%)\n\n\n\n\nHypertension\n777,130 (75%)\n718,885 (75%)\n58,245 (69%)\n&lt;0.001\n\n\nDiabetes mellitus\n349,470 (34%)\n324,805 (34%)\n24,665 (29%)\n&lt;0.001\n\n\nCancer\n46,945 (4.5%)\n43,535 (4.6%)\n3,410 (4.1%)\n0.004\n\n\nHeart failure\n264,480 (25%)\n240,365 (25%)\n24,115 (29%)\n&lt;0.001\n\n\nHyperlipidemia\n507,855 (49%)\n473,180 (49%)\n34,675 (41%)\n&lt;0.001\n\n\nCoronary artery disease\n297,785 (29%)\n276,590 (29%)\n21,195 (25%)\n&lt;0.001\n\n\nPeripheral vascular disease\n87,935 (8.5%)\n81,530 (8.5%)\n6,405 (7.6%)\n&lt;0.001\n\n\nChronic kidney disease\n251,930 (24%)\n232,740 (24%)\n19,190 (23%)\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n244,775 (24%)\n223,150 (23%)\n21,625 (26%)\n&lt;0.001\n\n\nCardiac arrhythmia\n356,825 (34%)\n324,595 (34%)\n32,230 (38%)\n&lt;0.001\n\n\nDementia\n373,105 (36%)\n329,805 (34%)\n43,300 (52%)\n&lt;0.001\n\n\nLiver disease\n35,050 (3.4%)\n32,240 (3.4%)\n2,810 (3.4%)\n0.9\n\n\nFluid and electrolyte disorders\n414,130 (40%)\n364,695 (38%)\n49,435 (59%)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Clinical and Economic Outcomes Associated with Aspiration Pneumonia in Hospitalized Patients with Parkinson’s Disease: A National Inpatient Sample Analysis",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall\nN = 1,040,0551\nParkinson’s disease without aspiration pneumonia\nN = 956,2001\nParkinson’s disease with aspiration pneumonia\nN = 83,8551\np-value2\n\n\n\n\nDied during hospitalization\n41,695 (4.0%)\n30,420 (3.2%)\n11,275 (13%)\n&lt;0.001\n\n\nLength of stay (days)\n5.9 (7.2)\n5.7 (6.9)\n8.8 (9.6)\n&lt;0.001\n\n\nInflation-adjusted total charge ($)\n62,963 (80,925)\n59,949 (73,380)\n97,293 (136,110)\n&lt;0.001\n\n\nSepsis\n159,075 (15%)\n123,225 (13%)\n35,850 (43%)\n&lt;0.001\n\n\nAcute respiratory failure\n118,660 (11%)\n83,435 (8.7%)\n35,225 (42%)\n&lt;0.001\n\n\nMechanical Ventilation\n42,515 (4.1%)\n28,595 (3.0%)\n13,920 (17%)\n&lt;0.001\n\n\nDischarged to home\n502,165 (48%)\n475,415 (50%)\n26,750 (32%)\n&lt;0.001\n\n\nTransferred to another short-term hospital\n\n\n\n\n\n\n\n\n\n\n    No\n1,040,055 (100%)\n956,200 (100%)\n83,855 (100%)\n\n\n\n\nTransferred to skilled nursing facility, intermediate care, or another facility\n467,330 (45%)\n423,740 (44%)\n43,590 (52%)\n&lt;0.001\n\n\nPalliative care utilization\n80,180 (7.7%)\n60,205 (6.3%)\n19,975 (24%)\n&lt;0.001\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Clinical and Economic Outcomes Associated with Aspiration Pneumonia in Hospitalized Patients with Parkinson’s Disease: A National Inpatient Sample Analysis",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n3.55\n3.35, 3.76\n&lt;0.001\n\n\nAge, y\n1.04\n1.03, 1.04\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.11\n1.06, 1.17\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.43\n1.26, 1.62\n&lt;0.001\n\n\n    Black\n1.20\n1.09, 1.32\n&lt;0.001\n\n\n    Hispanic\n1.22\n1.12, 1.33\n&lt;0.001\n\n\n    Native American\n1.15\n0.77, 1.70\n0.5\n\n\n    Other\n1.24\n1.08, 1.42\n0.002\n\n\nElixhauser comorbidity index\n1.10\n1.08, 1.12\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.98\n0.91, 1.04\n0.5\n\n\n    $66,000 - $87,999\n0.95\n0.88, 1.02\n0.2\n\n\n    $88,000 or more\n0.95\n0.87, 1.03\n0.2\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.60\n0.51, 0.71\n&lt;0.001\n\n\n    Medicare\n0.51\n0.47, 0.56\n&lt;0.001\n\n\n    Other\n1.59\n1.35, 1.86\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.26\n1.16, 1.38\n&lt;0.001\n\n\n    South\n0.91\n0.84, 0.98\n0.010\n\n\n    West\n1.07\n0.99, 1.17\n0.11\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n0.94\n0.88, 1.01\n0.11\n\n\n    Metro 250,000-999,999\n1.02\n0.94, 1.10\n0.7\n\n\n    Metro 50,000-249,999\n1.07\n0.97, 1.19\n0.2\n\n\n    Micropolitan\n1.08\n0.98, 1.19\n0.14\n\n\n    Other\n1.23\n1.10, 1.37\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.72\n0.68, 0.77\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.88, 0.98\n0.009\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.23\n1.11, 1.35\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.19\n1.12, 1.26\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.71, 0.79\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.93, 1.04\n0.6\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.90, 1.06\n0.6\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.91, 1.03\n0.3\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.83\n0.78, 0.88\n&lt;0.001\n\n\nCardiac arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.32\n1.25, 1.40\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.21\n1.15, 1.27\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.10\n1.91, 2.32\n&lt;0.001\n\n\nFluid and electrolyte disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.92\n1.82, 2.03\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nAcute Respiratory Failure:\n\n\nSepsis:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPD_AP\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n3.93\n3.79, 4.09\n&lt;0.001\n\n\nAGE\n1.00\n1.00, 1.00\n0.014\n\n\nFEMALE\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.25\n1.21, 1.28\n&lt;0.001\n\n\nRACE\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.17\n1.08, 1.26\n&lt;0.001\n\n\n    Black\n1.09\n1.03, 1.14\n0.002\n\n\n    Hispanic\n1.17\n1.11, 1.23\n&lt;0.001\n\n\n    Native American\n1.11\n0.88, 1.39\n0.4\n\n\n    Other\n1.09\n1.00, 1.19\n0.040\n\n\nelixsum\n1.05\n1.04, 1.06\n&lt;0.001\n\n\nZIPINC_QRTL\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.97\n0.93, 1.01\n0.11\n\n\n    $66,000 - $87,999\n0.95\n0.91, 0.99\n0.009\n\n\n    $88,000 or more\n0.92\n0.88, 0.96\n&lt;0.001\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.14\n1.04, 1.24\n0.004\n\n\n    Medicare\n1.03\n0.97, 1.08\n0.3\n\n\n    Other\n1.14\n1.03, 1.27\n0.013\n\n\nHosp_Census_Region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.12\n1.07, 1.18\n&lt;0.001\n\n\n    South\n1.05\n1.01, 1.10\n0.027\n\n\n    West\n1.37\n1.30, 1.44\n&lt;0.001\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n0.96\n0.92, 1.01\n0.088\n\n\n    Metro 250,000-999,999\n0.92\n0.88, 0.96\n&lt;0.001\n\n\n    Metro 50,000-249,999\n0.94\n0.88, 0.99\n0.029\n\n\n    Micropolitan\n0.89\n0.84, 0.94\n&lt;0.001\n\n\n    Other\n0.84\n0.78, 0.90\n&lt;0.001\n\n\nHTN\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.73, 0.78\n&lt;0.001\n\n\nDM\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.19\n1.16, 1.23\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n0.96, 1.08\n0.6\n\n\nCHF\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.05\n1.02, 1.09\n0.004\n\n\nHyperlip\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.82, 0.87\n&lt;0.001\n\n\nCAD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.84\n0.81, 0.87\n&lt;0.001\n\n\nPVD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.99\n0.94, 1.04\n0.7\n\n\nCKD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n1.0, 1.07\n0.10\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n1.02, 1.09\n0.002\n\n\nCardiac_arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n1.00, 1.07\n0.053\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.44\n1.40, 1.48\n&lt;0.001\n\n\nLiver_Dis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.16\n1.08, 1.24\n&lt;0.001\n\n\nFluid_disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.53\n2.45, 2.60\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nUtilization of mechanical ventilation:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPD_AP\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n5.40\n5.10, 5.72\n&lt;0.001\n\n\nAGE\n0.97\n0.97, 0.98\n&lt;0.001\n\n\nFEMALE\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.07\n1.02, 1.12\n0.009\n\n\nRACE\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.57\n1.39, 1.78\n&lt;0.001\n\n\n    Black\n1.53\n1.41, 1.67\n&lt;0.001\n\n\n    Hispanic\n1.38\n1.27, 1.50\n&lt;0.001\n\n\n    Native American\n1.90\n1.37, 2.62\n&lt;0.001\n\n\n    Other\n1.35\n1.18, 1.55\n&lt;0.001\n\n\nelixsum\n1.09\n1.07, 1.11\n&lt;0.001\n\n\nZIPINC_QRTL\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.93\n0.87, 0.99\n0.030\n\n\n    $66,000 - $87,999\n0.85\n0.79, 0.91\n&lt;0.001\n\n\n    $88,000 or more\n0.74\n0.68, 0.80\n&lt;0.001\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.05\n0.91, 1.20\n0.5\n\n\n    Medicare\n1.02\n0.94, 1.12\n0.6\n\n\n    Other\n1.03\n0.86, 1.25\n0.7\n\n\nHosp_Census_Region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.14\n1.06, 1.24\n0.001\n\n\n    South\n1.03\n0.96, 1.11\n0.4\n\n\n    West\n1.08\n1.00, 1.18\n0.054\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n0.93\n0.87, 1.00\n0.041\n\n\n    Metro 250,000-999,999\n0.81\n0.75, 0.88\n&lt;0.001\n\n\n    Metro 50,000-249,999\n0.80\n0.72, 0.88\n&lt;0.001\n\n\n    Micropolitan\n0.78\n0.70, 0.86\n&lt;0.001\n\n\n    Other\n0.81\n0.72, 0.90\n&lt;0.001\n\n\nHTN\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.75, 0.84\n&lt;0.001\n\n\nDM\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n1.00, 1.12\n0.045\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.89\n0.80, 1.00\n0.050\n\n\nCHF\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.32\n1.24, 1.41\n&lt;0.001\n\n\nHyperlip\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.76, 0.84\n&lt;0.001\n\n\nCAD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.90\n0.85, 0.95\n&lt;0.001\n\n\nPVD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.93\n0.85, 1.02\n0.12\n\n\nCKD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.75, 0.85\n&lt;0.001\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.07\n1.01, 1.14\n0.016\n\n\nCardiac_arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.57\n1.48, 1.66\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.96\n0.91, 1.01\n0.2\n\n\nLiver_Dis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.65\n1.49, 1.82\n&lt;0.001\n\n\nFluid_disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2.74\n2.59, 2.90\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nDischarged to home:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPD_AP\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n0.57\n0.55, 0.60\n&lt;0.001\n\n\nAGE\n0.98\n0.98, 0.98\n&lt;0.001\n\n\nFEMALE\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.01\n0.99, 1.03\n0.4\n\n\nRACE\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.21\n1.13, 1.29\n&lt;0.001\n\n\n    Black\n1.00\n0.96, 1.04\n&gt;0.9\n\n\n    Hispanic\n1.36\n1.30, 1.42\n&lt;0.001\n\n\n    Native American\n1.12\n0.94, 1.34\n0.2\n\n\n    Other\n1.13\n1.06, 1.21\n&lt;0.001\n\n\nelixsum\n0.96\n0.95, 0.97\n&lt;0.001\n\n\nZIPINC_QRTL\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.98\n0.95, 1.01\n0.2\n\n\n    $66,000 - $87,999\n1.00\n0.97, 1.04\n0.8\n\n\n    $88,000 or more\n1.08\n1.04, 1.12\n&lt;0.001\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.76\n0.71, 0.82\n&lt;0.001\n\n\n    Medicare\n0.73\n0.70, 0.76\n&lt;0.001\n\n\n    Other\n0.79\n0.73, 0.85\n&lt;0.001\n\n\nHosp_Census_Region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.97\n0.94, 1.01\n0.2\n\n\n    South\n1.21\n1.17, 1.25\n&lt;0.001\n\n\n    West\n1.31\n1.26, 1.37\n&lt;0.001\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n1.09\n1.06, 1.13\n&lt;0.001\n\n\n    Metro 250,000-999,999\n1.09\n1.05, 1.13\n&lt;0.001\n\n\n    Metro 50,000-249,999\n1.10\n1.06, 1.15\n&lt;0.001\n\n\n    Micropolitan\n1.05\n1.01, 1.09\n0.028\n\n\n    Other\n1.05\n1.00, 1.10\n0.059\n\n\nHTN\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n1.01, 1.06\n0.009\n\n\nDM\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.98, 1.02\n&gt;0.9\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.27\n1.21, 1.33\n&lt;0.001\n\n\nCHF\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n1.00, 1.05\n0.077\n\n\nHyperlip\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n1.12, 1.16\n&lt;0.001\n\n\nCAD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.14\n1.11, 1.16\n&lt;0.001\n\n\nPVD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.10\n1.06, 1.14\n&lt;0.001\n\n\nCKD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.03\n1.00, 1.05\n0.026\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.17\n1.14, 1.20\n&lt;0.001\n\n\nCardiac_arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.98, 1.03\n0.6\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.56\n0.55, 0.57\n&lt;0.001\n\n\nLiver_Dis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.06\n1.00, 1.11\n0.041\n\n\nFluid_disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.71, 0.75\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nTransferred to short-term facility:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPD_AP\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n1.00\n0.98, 1.02\n&gt;0.9\n\n\nAGE\n1.00\n1.00, 1.00\n&gt;0.9\n\n\nFEMALE\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.00\n0.99, 1.01\n&gt;0.9\n\n\nRACE\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.00\n0.93, 1.07\n&gt;0.9\n\n\n    Black\n1.00\n0.96, 1.04\n&gt;0.9\n\n\n    Hispanic\n1.00\n0.95, 1.05\n&gt;0.9\n\n\n    Native American\n1.00\n0.89, 1.13\n&gt;0.9\n\n\n    Other\n1.00\n0.93, 1.08\n&gt;0.9\n\n\nelixsum\n1.00\n0.99, 1.01\n&gt;0.9\n\n\nZIPINC_QRTL\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.00\n0.97, 1.03\n&gt;0.9\n\n\n    $66,000 - $87,999\n1.00\n0.96, 1.04\n&gt;0.9\n\n\n    $88,000 or more\n1.00\n0.95, 1.05\n&gt;0.9\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.00\n0.96, 1.05\n&gt;0.9\n\n\n    Medicare\n1.00\n0.97, 1.03\n&gt;0.9\n\n\n    Other\n1.00\n0.95, 1.06\n&gt;0.9\n\n\nHosp_Census_Region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.00\n0.95, 1.05\n&gt;0.9\n\n\n    South\n1.00\n0.96, 1.04\n&gt;0.9\n\n\n    West\n1.00\n0.95, 1.05\n&gt;0.9\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n1.00\n0.94, 1.06\n&gt;0.9\n\n\n    Metro 250,000-999,999\n1.00\n0.93, 1.08\n&gt;0.9\n\n\n    Metro 50,000-249,999\n1.00\n0.92, 1.08\n&gt;0.9\n\n\n    Micropolitan\n1.00\n0.94, 1.06\n&gt;0.9\n\n\n    Other\n1.00\n0.94, 1.06\n&gt;0.9\n\n\nHTN\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.98, 1.02\n&gt;0.9\n\n\nDM\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.98, 1.02\n&gt;0.9\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.97, 1.03\n&gt;0.9\n\n\nCHF\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.98, 1.02\n&gt;0.9\n\n\nHyperlip\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.99, 1.01\n&gt;0.9\n\n\nCAD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.99, 1.01\n&gt;0.9\n\n\nPVD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.97, 1.03\n&gt;0.9\n\n\nCKD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.98, 1.02\n&gt;0.9\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.98, 1.02\n&gt;0.9\n\n\nCardiac_arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.98, 1.02\n&gt;0.9\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.99, 1.01\n&gt;0.9\n\n\nLiver_Dis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.97, 1.03\n&gt;0.9\n\n\nFluid_disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.00\n0.98, 1.02\n&gt;0.9\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nTransferred to skilled nursing facility, intermediate care, or another facility:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPD_AP\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n1.16\n1.12, 1.20\n&lt;0.001\n\n\nAGE\n1.02\n1.02, 1.02\n&lt;0.001\n\n\nFEMALE\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.96\n0.94, 0.98\n&lt;0.001\n\n\nRACE\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.77\n0.72, 0.82\n&lt;0.001\n\n\n    Black\n0.96\n0.92, 1.00\n0.058\n\n\n    Hispanic\n0.70\n0.67, 0.73\n&lt;0.001\n\n\n    Native American\n0.84\n0.71, 0.99\n0.037\n\n\n    Other\n0.82\n0.77, 0.88\n&lt;0.001\n\n\nelixsum\n1.03\n1.02, 1.03\n&lt;0.001\n\n\nZIPINC_QRTL\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.04\n1.01, 1.07\n0.006\n\n\n    $66,000 - $87,999\n1.02\n0.99, 1.05\n0.2\n\n\n    $88,000 or more\n0.96\n0.93, 1.00\n0.026\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.37\n1.28, 1.47\n&lt;0.001\n\n\n    Medicare\n1.58\n1.52, 1.64\n&lt;0.001\n\n\n    Other\n1.03\n0.95, 1.11\n0.5\n\n\nHosp_Census_Region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.97\n0.93, 1.00\n0.087\n\n\n    South\n0.84\n0.81, 0.87\n&lt;0.001\n\n\n    West\n0.72\n0.69, 0.75\n&lt;0.001\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n0.91\n0.88, 0.94\n&lt;0.001\n\n\n    Metro 250,000-999,999\n0.91\n0.88, 0.95\n&lt;0.001\n\n\n    Metro 50,000-249,999\n0.89\n0.85, 0.93\n&lt;0.001\n\n\n    Micropolitan\n0.88\n0.85, 0.92\n&lt;0.001\n\n\n    Other\n0.85\n0.81, 0.90\n&lt;0.001\n\n\nHTN\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n1.00, 1.05\n0.083\n\n\nDM\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.01\n0.99, 1.04\n0.3\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.75\n0.72, 0.78\n&lt;0.001\n\n\nCHF\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.91, 0.96\n&lt;0.001\n\n\nHyperlip\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.92\n0.91, 0.94\n&lt;0.001\n\n\nCAD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.87\n0.85, 0.89\n&lt;0.001\n\n\nPVD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.88, 0.95\n&lt;0.001\n\n\nCKD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.98\n0.95, 1.00\n0.051\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.89\n0.87, 0.91\n&lt;0.001\n\n\nCardiac_arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.94\n0.92, 0.96\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.74\n1.71, 1.78\n&lt;0.001\n\n\nLiver_Dis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.75, 0.83\n&lt;0.001\n\n\nFluid_disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.24\n1.21, 1.27\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio\n\n\n\n\n\n\n\n\n\n\nUtilization of Palliative Care:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n95% CI\np-value\n\n\n\n\nPD_AP\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n3.52\n3.36, 3.69\n&lt;0.001\n\n\nAGE\n1.04\n1.04, 1.05\n&lt;0.001\n\n\nFEMALE\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.10\n1.06, 1.14\n&lt;0.001\n\n\nRACE\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.08\n0.97, 1.21\n0.2\n\n\n    Black\n1.09\n1.02, 1.18\n0.016\n\n\n    Hispanic\n1.00\n0.92, 1.08\n&gt;0.9\n\n\n    Native American\n1.18\n0.85, 1.64\n0.3\n\n\n    Other\n0.93\n0.83, 1.05\n0.2\n\n\nelixsum\n1.15\n1.13, 1.17\n&lt;0.001\n\n\nZIPINC_QRTL\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n1.03\n0.98, 1.09\n0.3\n\n\n    $66,000 - $87,999\n1.04\n0.98, 1.11\n0.2\n\n\n    $88,000 or more\n1.11\n1.04, 1.18\n0.002\n\n\nInsurance\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.75\n0.65, 0.86\n&lt;0.001\n\n\n    Medicare\n0.62\n0.57, 0.66\n&lt;0.001\n\n\n    Other\n1.68\n1.47, 1.92\n&lt;0.001\n\n\nHosp_Census_Region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.84\n0.78, 0.90\n&lt;0.001\n\n\n    South\n0.83\n0.78, 0.89\n&lt;0.001\n\n\n    West\n0.85\n0.79, 0.91\n&lt;0.001\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n1.05\n0.99, 1.12\n0.086\n\n\n    Metro 250,000-999,999\n1.12\n1.05, 1.20\n&lt;0.001\n\n\n    Metro 50,000-249,999\n1.08\n0.99, 1.17\n0.076\n\n\n    Micropolitan\n0.96\n0.88, 1.05\n0.4\n\n\n    Other\n0.84\n0.76, 0.93\n&lt;0.001\n\n\nHTN\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.70, 0.76\n&lt;0.001\n\n\nDM\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.77, 0.84\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.50\n1.39, 1.61\n&lt;0.001\n\n\nCHF\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.02\n0.97, 1.06\n0.5\n\n\nHyperlip\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.79\n0.76, 0.82\n&lt;0.001\n\n\nCAD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.87\n0.84, 0.91\n&lt;0.001\n\n\nPVD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.89\n0.83, 0.95\n&lt;0.001\n\n\nCKD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.85\n0.81, 0.89\n&lt;0.001\n\n\nCOPD\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.77\n0.73, 0.81\n&lt;0.001\n\n\nCardiac_arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.95\n0.91, 0.99\n0.022\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.91\n1.84, 1.98\n&lt;0.001\n\n\nLiver_Dis\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.28\n1.17, 1.40\n&lt;0.001\n\n\nFluid_disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1.48\n1.42, 1.54\n&lt;0.001\n\n\n\nAbbreviations: CI = Confidence Interval, OR = Odds Ratio"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Clinical and Economic Outcomes Associated with Aspiration Pneumonia in Hospitalized Patients with Parkinson’s Disease: A National Inpatient Sample Analysis",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n2.6\n2.5, 2.8\n&lt;0.001\n\n\nAge, y\n-0.04\n-0.05, -0.04\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.36\n0.29, 0.42\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.38\n0.12, 0.64\n0.004\n\n\n    Black\n0.97\n0.81, 1.1\n&lt;0.001\n\n\n    Hispanic\n0.10\n-0.04, 0.25\n0.2\n\n\n    Native American\n0.21\n-0.25, 0.67\n0.4\n\n\n    Other\n0.65\n0.33, 0.97\n&lt;0.001\n\n\nElixhauser comorbidity index\n0.54\n0.51, 0.57\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.10\n-0.20, -0.01\n0.039\n\n\n    $66,000 - $87,999\n-0.16\n-0.26, -0.05\n0.003\n\n\n    $88,000 or more\n-0.32\n-0.44, -0.20\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n1.1\n0.73, 1.4\n&lt;0.001\n\n\n    Medicare\n-0.04\n-0.18, 0.10\n0.6\n\n\n    Other\n-0.31\n-0.66, 0.04\n0.084\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.85\n0.72, 0.98\n&lt;0.001\n\n\n    South\n0.03\n-0.06, 0.13\n0.5\n\n\n    West\n-0.22\n-0.35, -0.09\n&lt;0.001\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n-0.25\n-0.37, -0.14\n&lt;0.001\n\n\n    Metro 250,000-999,999\n-0.32\n-0.44, -0.20\n&lt;0.001\n\n\n    Metro 50,000-249,999\n-0.34\n-0.48, -0.19\n&lt;0.001\n\n\n    Micropolitan\n-0.38\n-0.53, -0.23\n&lt;0.001\n\n\n    Other\n-0.21\n-0.38, -0.04\n0.015\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.53\n-0.61, -0.44\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.50\n-0.58, -0.42\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.25\n0.09, 0.41\n0.002\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.19\n-0.28, -0.11\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.33\n-0.40, -0.27\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.23\n-0.30, -0.16\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.55\n-0.66, -0.44\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.40\n-0.48, -0.32\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.58\n-0.67, -0.50\n&lt;0.001\n\n\nCardiac arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.11\n-0.19, -0.04\n0.003\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.86\n0.78, 0.94\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.59\n-0.77, -0.41\n&lt;0.001\n\n\nFluid and electrolyte disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.80\n0.72, 0.87\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Parkinson's disease without aspiration pneumonia\n—\n—\n\n\n\n\n    Parkinson's disease with aspiration pneumonia\n33,200\n30,789, 35,610\n&lt;0.001\n\n\nAge, y\n-689\n-740, -638\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n3,362\n2,629, 4,094\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n11,877\n7,341, 16,413\n&lt;0.001\n\n\n    Black\n2,807\n1,037, 4,576\n0.002\n\n\n    Hispanic\n13,726\n11,012, 16,439\n&lt;0.001\n\n\n    Native American\n-9,338\n-13,607, -5,070\n&lt;0.001\n\n\n    Other\n14,294\n10,109, 18,479\n&lt;0.001\n\n\nElixhauser comorbidity index\n4,851\n4,297, 5,405\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-132\n-1,362, 1,098\n0.8\n\n\n    $66,000 - $87,999\n-1,277\n-2,640, 86\n0.066\n\n\n    $88,000 or more\n793\n-1,206, 2,792\n0.4\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-2,707\n-6,058, 644\n0.11\n\n\n    Medicare\n-2,197\n-3,846, -547\n0.009\n\n\n    Other\n-5,184\n-8,328, -2,041\n0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n14,758\n12,443, 17,074\n&lt;0.001\n\n\n    South\n12,620\n11,090, 14,150\n&lt;0.001\n\n\n    West\n30,165\n27,302, 33,029\n&lt;0.001\n\n\nPL_NCHS\n\n\n\n\n\n\n\n\n    Central metro ≥1 million\n—\n—\n\n\n\n\n    Fringe metro ≥1 million\n-7,274\n-9,454, -5,095\n&lt;0.001\n\n\n    Metro 250,000-999,999\n-10,811\n-13,214, -8,408\n&lt;0.001\n\n\n    Metro 50,000-249,999\n-18,045\n-20,264, -15,826\n&lt;0.001\n\n\n    Micropolitan\n-20,305\n-22,422, -18,189\n&lt;0.001\n\n\n    Other\n-22,651\n-24,821, -20,481\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,899\n-5,953, -3,844\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,428\n-5,446, -3,410\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n5,496\n3,615, 7,376\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n1,006\n-210, 2,221\n0.10\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-504\n-1,267, 260\n0.2\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3,067\n2,229, 3,905\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-172\n-1,755, 1,411\n0.8\n\n\nChronic kidney disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-5,379\n-6,415, -4,343\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-4,998\n-6,102, -3,894\n&lt;0.001\n\n\nCardiac arrhythmia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n4,338\n3,319, 5,358\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,699\n-3,469, -1,929\n&lt;0.001\n\n\nLiver disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n3,188\n286, 6,090\n0.031\n\n\nFluid and electrolyte disorders\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n8,103\n7,078, 9,128\n&lt;0.001\n\n\n\nAbbreviation: CI = Confidence Interval"
  }
]